Literature DB >> 6342646

Monoclonal antibodies to human colon and colorectal carcinoma.

C H Thompson, S L Jones, E Pihl, I F McKenzie.   

Abstract

A series of monoclonal antibodies was produced by immunizing mice with fresh carcinoma of the colon and with the cell line HT-29. These antibodies could be classified into 3 different groups: (a) those which were HT-29 specific and reacted with no other cell line or fresh colon carcinoma samples; (b) antibodies which reacted with HT-29 and were also reactive with a number of other in vitro cell lines; and (c) antibodies which appeared to be specific for carcinoma of the colon cell lines in that they reacted selectively with colon carcinoma cell lines and not with carcinoma lines derived from other tissues. It was clearly shown by immunoperoxidase staining of both normal and neoplastic cells of the gastrointestinal mucosa, from stomach to colon, that these antibodies were not tumour-specific. Indeed, one antibody (250-30.6) has a remarkable specificity for secretory epithelium of any tissue whether it be found in the gastrointestinal tract, respiratory system or urinary system. We question the existence of tumour-specific antigens detected by monoclonal antisera described thus far, and comment on the remarkable specificity of some of the sera produced, emphasized by the secretory cell-specific antibody described herein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342646      PMCID: PMC2011388          DOI: 10.1038/bjc.1983.97

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Exposed protein on the intact human erythrocyte.

Authors:  D R Phillips; M Morrison
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

2.  A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera.

Authors:  C R Parish; I F McKenzie
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  Cell surface antigens of human melanoma identified by monoclonal antibody.

Authors:  M Y Yeh; I Hellström; J P Brown; G A Warner; J A Hansen; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

4.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

5.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

6.  Persistence of organ- and iso-antigens in vitro in a long-term culture cell line of colonic carcinoma.

Authors:  S L Jones; D Quinn; J Ma; H A Ward; E Pihl; R C Nairn
Journal:  Pathology       Date:  1982-10       Impact factor: 5.306

7.  Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain.

Authors:  R H Kennett; F Gilbert
Journal:  Science       Date:  1979-03-16       Impact factor: 47.728

8.  Study of antibodies against human melanoma produced by somatic cell hybrids.

Authors:  H Koprowski; Z Steplewski; D Herlyn; M Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Two-gene control of the expression of a murine Ia antigen.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Another oncofoetal antigen in colonic carcinoma.

Authors:  J Ma; W G de Boer; H A Ward; R C Nairn
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

View more
  2 in total

1.  Colonic epithelium reactive monoclonal antibodies. Identification and immunohistochemical localization of the target epitopes.

Authors:  C P Verstijnen; J W Arends; P T Moerkerk; M Pijls; B Kuypers-Engelen; F T Bosman
Journal:  Histochemistry       Date:  1989

2.  Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker.

Authors:  G Moldenhauer; F Momburg; P Möller; R Schwartz; G J Hämmerling
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.